NCT00624975 - Safety and Immunogenicity of Peru-15 Vaccine When Given With Measles Vaccine in Healthy Indian and Bangladeshi Infants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

CholeraDiarrheaVibrio Infections

Interventions

BIOLOGICAL

Peru-15 Vaccine

up to 1 x 10\^9 CFU of Peru-15 given in 5ml single dose vials with 20 ml buffer solution, given once

BIOLOGICAL

Placebo

25 mL of buffer solution (2.5 g sodium bicarbonate and 1.65 g ascorbic acid per 100mL potable water)

Trial Locations (2)

International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka

Christian Medical College, Vellore